Encompass Health sets April 30 Q1 results release and Zacks Buy upgrade
Encompass Health will report Q1 results for period ended March 31, 2026 after market close on April 30 and host a May 1 conference call at 10 a.m. ET. Zacks upgraded Encompass Health to a Buy (Rank #2), reflecting growing optimism in its earnings prospects.
1. Q1 Earnings Call Scheduled
Encompass Health will report first-quarter 2026 results for the period ended March 31 on April 30 after market close and host an investor conference call at 10 a.m. ET on May 1. Dial-in numbers are 800-267-6316 (domestic) or 203-518-9783 (international) with conference ID EHCQ126; a live webcast and replay will be available on the company’s investor website.
2. Zacks Upgrades to Buy
Zacks Investment Research raised Encompass Health to a Buy rating (Rank #2), citing strengthening patient volumes and favorable reimbursement trends. The upgrade underscores growing confidence in the company’s margin expansion and revenue growth prospects for the upcoming quarters.